Lv41
460 积分 2024-03-01 加入
A randomized, double-blind, placebo-controlled, single- and multiple-dose phase 1 study of VE202, a defined bacterial consortium for treatment of inflammatory bowel disease: safety and colonization dynamics of a novel live biotherapeutic product in healthy adults
1小时前
求助中
Clostridioides difficile infections; new treatments and future perspectives
9天前
已关闭
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile)
9天前
已完结
Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial
15天前
已完结
The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection
15天前
已关闭
Butyrate’s role in human health and the current progress towards its clinical application to treat gastrointestinal disease
18天前
已完结
A new perspective in the prevention and treatment of antitumor therapy-related cardiotoxicity: Intestinal microecology
18天前
已关闭
The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer
18天前
已完结
How bile acids and the microbiota interact to shape host immunity
18天前
已完结
Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation
18天前
已完结
皖公网安备34019202002308
